Back to Authors

Chodnicki, Kevin D.

https://orcid.org/0000-0002-6815-8272

Mayo Clinic

Mayo Clinic

Citations 17

The Frequency of Optic Disc Hemorrhages and Other Retinal Findings on Fundoscopic Examination in Acute MOGAD Optic Neuritis (P11-8.005)
Welk, Grant M., Tajfirouz, Deena , Chodnicki, Kevin D. , Pittock, Sean J, Chen, John , Welk, Grant M. , Tisavipat, Nanthaya , Rattanathamsakul, Natthapon , Lang, Mary, Pittock, Sean J. , Flanagan, Eoin P.

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208847 Get It

The Relative Frequency of Severe Vision Loss from Central Retinal Artery Occlusion Versus Anterior Ischemic Optic Neuropathy (P5-11.014)
Dogahe, Sepideh Jamali, Tajifirouz, Deena, Chodnicki, Kevin D. , Chen, John J.

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211402 Get It

Frequency of Increased Intracranial Pressure in MOGAD (S32.010)
Salman, Abdul-Rahman , Redenbaugh, Vyanka , Tajfirouz, Deena , Chodnicki, Kevin D. , Tillema, Jan‐Mendelt , Salman, Abdul-Rahman , Tisavipat, Nanthaya , Rattanathamsakul, Natthapon , Cacciaguerra, Laura , Pittock, Sean J. , Flanagan, Eoin P. , Chen, John J.

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206730 Get It

Atypical Bilateral Idiopathic Inflammatory Cavernous Sinus Syndrome Responsive to Cyclophosphamide
Nathoo, Nabeela , Chodnicki, Kevin D. , Krecke, Karl N. , Nguyen, Aivi T. , Toledano, Michel , Kantarci, Orhun H. , Nguyen, Aivi T , Nathoo, Nabeela , Gompel, Jamie J. Van

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques | March 5, 2024 | Volume: 52 | Issue: 1 | Pages: 159-161

10.1017/cjn.2024.29 Get It

Pigmented Macular Lesion in a Child
Chodnicki, Kevin D. , Brodsky, Michael C., Olsen, Timothy W.

JAMA Ophthalmology | July 3, 2019 | Volume: 137 | Issue: 9 | Pages: 1076

10.1001/jamaophthalmol.2019.1659 Get It

A Systematic Evaluation of State Laws Governing Optometric Glaucoma Management in the United States Upto 2015
Chodnicki, Kevin D. , Kalarn, Sachin , Quinn, Laura A. , Jampel, Henry , Chodnicki, Kevin, Saeedi, Osamah J.

Journal of Glaucoma | January 5, 2018 | Volume: 27 | Issue: 3 | Pages: 233-238

10.1097/ijg.0000000000000861 Get It

Purpose: To describe state laws that govern the optometric practice of glaucoma management in the United States and to correlate those laws with state demographics upto 2015. Materials and Methods: We performed a cross-sectional ecological study of the 50 United States and the District of Columbia. Regulations governing optometric scope of practice as written by each state Board of Optometry were reviewed. Specific optometric privileges assessed included: ability to manage glaucoma independently, use of diagnostic pharmaceutical agents, use of therapeutic pharmaceutical agents (including topical and oral steroids and other oral pharmaceutical agents), IV injections, intraocular injections, therapeutic lasers, presence of defined referral, and comanagement guidelines, and hours of yearly continuing education needed for glaucoma management. Optometric privilege was compared with demographic and employment information for each state. Results: Optometrists in all states, except for Massachusetts, and the District of Columbia are allowed to manage glaucoma; 16 states have defined comanagement guidelines. Therapeutic lasers are allowed in 3 states: Kentucky, Louisiana, and Oklahoma. States with defined comanagement guidelines had a mean of 6.9±1.9 ophthalmologists per 100,000 people, significantly more than the 5.3±1.1 in states without defined comanagement of glaucoma (P<0.01). Binary logistic regression showed that, accounting for population and area, the higher the number of optometrists in a state, the less likely there is to be defined comanagement [β (SE)=−0.008 (0.003), P=0.02] and the greater the number of ophthalmologists in a given state, the more likely a state has defined comanagement [β (SE)=−0.13 (0.006)]. Conclusions: There is a diversity of regulations that govern optometric management of glaucoma in each of the 50 states and the District of Columbia. The number of optometrists and ophthalmologists in a state may influence state regulations governing optometric practice and referral guidelines.